Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Zhou, Li ^a   Rua, Rejane ^a,e   Ng, Thomas ^b   Vongrad, Valentina ^a   Ho, Yung S ^a   Geczy, Carolyn ^c   Hsu, Kenneth ^c   Brew, Bruce J ^d   Saksena, Nitin K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CALGRANULIN A; CD8 ANTIGEN; CD86 ANTIGEN; CLOTRIMAZOLE; DIDANOSINE; GRANZYME B; ZIDOVUDINE; GAG PROTEIN; P24 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1;

ARTICLE; B CELL LYMPHOMA; BASAL GANGLION; BRAIN REGION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CLINICAL ARTICLE; COGNITION; CYTOMEGALOVIRUS INFECTION; DEMENTIA; DISEASE ASSOCIATION; DISEASE DURATION; ENCEPHALITIS; FEMALE; FRONTAL LOBE; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MEDULLA OBLONGATA; OCCIPITAL LOBE; PHYLOGENY; PROTEIN LOCALIZATION; SPINAL CORD DISEASE; THALAMUS; VIRUS ENTRY; VIRUS LOAD; ADULT; BRAIN; GENETICS; HIV ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; VIROLOGY;

ADULT; AIDS DEMENTIA COMPLEX; BASE SEQUENCE; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; FEMALE; HIV CORE PROTEIN P24; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION;

EID: 72549114622     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-192     Document Type: Article

References (42)

1. Gray F, Geny C, Lionnet F, Dournon E, Fenelon G, Gherardi R, Poirier J. [Neuropathologic study of 135 adult cases of acquired immunodeficiency syndrome (AIDS)]. Annales de pathologie 1991, 11(4):236-247.
2. Anders K, Steinsapir KD, Iverson DJ, Glasgow BJ, Layfield LJ, Brown WJ, Cancilla PA, Verity MA, Vinters HV. Neuropathologic findings in the acquired immunodeficiency syndrome (AIDS). Clinical neuropathology 1986, 5(1):1-20.
3. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Annals of neurology 1986, 19(6):525-535. 10.1002/ana.410190603, 3014994.
4. Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. Journal of neuropathology and experimental neurology 1986, 45(6):635-646. 10.1097/00005072-198611000-00003, 3021914.
5. Albright AV, Soldan SS, Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. Journal of neurovirology 2003, 9(2):222-227. 10.1080/713831483, 12707852.
6. Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Progress in neurobiology 1998, 54(1):19-33. 10.1016/S0301-0082(97)00053-1, 9460791.
7. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC. HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001, 56(2):257-260.
8. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999) 2002, 31(2):171-177.
9. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (London, England) 2003, 17(10):1539-1545.
10. Lawrence DM, Major EO. HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes and infection/Institut Pasteur 2002, 4(3):301-308.
11. Bossi P, Dupin N, Coutellier A, Bricaire F, Lubetzki C, Katlama C, Calvez V. The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis. Clin Infect Dis 1998, 26(5):1072-1073. 10.1086/520301, 9597227.
12. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Annals of neurology 1997, 42(5):679-688. 10.1002/ana.410420503, 9392566.
13. Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Annals of neurology 1993, 33(5):429-436. 10.1002/ana.410330502, 8498818.
14. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Annals of neurology 1995, 38(5):755-762. 10.1002/ana.410380510, 7486867.
15. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet 1997, 349(9053):692-695. 10.1016/S0140-6736(96)10178-1, 9078201.
16. Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L. The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. Journal of neurovirology 1996, 2(3):152-157. 10.3109/13550289609146877, 8799207.
17. An SF, Groves M, Giometto B, Beckett AA, Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta neuropathologica 1999, 98(5):481-487. 10.1007/s004010051113, 10541871.
18. Argyris EG, Acheampong E, Nunnari G, Mukhtar M, Williams KJ, Pomerantz RJ. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. Journal of virology 2003, 77(22):12140-12151. 10.1128/JVI.77.22.12140-12151.2003, 254292, 14581551.
19. Dalod M, Dupuis M, Deschemin JC, Goujard C, Deveau C, Meyer L, Ngo N, Rouzioux C, Guillet JG, Delfraissy JF. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. The Journal of clinical investigation 1999, 104(10):1431-1439. 10.1172/JCI7162, 409838, 10562305.
20. Sopper S, Sauer U, Hemm S, Demuth M, Muller J, Stahl-Hennig C, Hunsmann G, ter Meulen V, Dorries R. Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. Journal of virology 1998, 72(12):9940-9947. 110507, 9811731.
21. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (New York, NY) 1999, 283(5403):857-860.
22. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (New York, NY) 1998, 279(5359):2103-2106.
23. Nehete PN, Lewis DE, Tang DN, Pollack MS, Sastry KJ. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus. Viral immunology 1998, 11(3):119-129. 10.1089/vim.1998.11.119, 9918403.
24. Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol 1992, 149(9):3113-3119.
25. Petito CK, Torres-Munoz JE, Zielger F, McCarthy M. Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. Journal of neurovirology 2006, 12(4):272-283. 10.1080/13550280600879204, 16966218.
26. Zhu Y, Antony J, Liu S, Martinez JA, Giuliani F, Zochodne D, Power C. CD8+ lymphocyte-mediated injury of dorsal root ganglion neurons during lentivirus infection: CD154-dependent cell contact neurotoxicity. J Neurosci 2006, 26(13):3396-3403. 10.1523/JNEUROSCI.4767-05.2006, 16571746.
27. Marcondes MC, Burudi EM, Huitron-Resendiz S, Sanchez-Alavez M, Watry D, Zandonatti M, Henriksen SJ, Fox HS. Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol 2001, 167(9):5429-5438.
28. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Annals of neurology 1995, 38(4):563-570. 10.1002/ana.410380404, 7574452.
29. Neuen-Jacob E, Arendt G, Wendtland B, Jacob B, Schneeweis M, Wechsler W. Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clinical neuropathology 1993, 12(6):315-324.
30. Zhou L, Ng T, Yuksel A, Wang B, Dwyer DE, Saksena NK. Short communication: absence of HIV infection in the choroid plexus of two patients who died rapidly with HIV-associated dementia. AIDS research and human retroviruses 2008, 24(6):839-843. 10.1089/aid.2007.0147, 18544025.
31. Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman BB, Saksena NK. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of virology 2004, 78(18):10133-10148. 10.1128/JVI.78.18.10133-10148.2004, 515019, 15331746.
32. Huson LW, Chung J, Salgo M. Multiple polyexponentials and quasipolynomials as empirical nonlinear regression models: a case study with HIV viral load data. Journal of biopharmaceutical statistics 2006, 16(2):165-179. 10.1080/10543400500508788, 16584065.
33. Bandelt HJ, Forster P, Sykes BC, Richards MB. Mitochondrial portraits of human populations using median networks. Genetics 1995, 141(2):743-753. 1206770, 8647407.
34. Engel S, Schluesener H, Mittelbronn M, Seid K, Adjodah D, Wehner HD, Meyermann R. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta neuropathologica 2000, 100(3):313-322. 10.1007/s004019900172, 10965802.
35. Seeliger S, Vogl T, Engels IH, Schroder JM, Sorg C, Sunderkotter C, Roth J. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. The American journal of pathology 2003, 163(3):947-956. 1868263, 12937135.
36. Postler E, Lehr A, Schluesener H, Meyermann R. Expression of the S-100 proteins MRP-8 and -14 in ischemic brain lesions. Glia 1997, 19(1):27-34. 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7, 8989565.
37. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 2007, 15(4):114-117.
38. Price TO, Ercal N, Nakaoke R, Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain research 2005, 1045(1-2):57-63.
39. Toborek M, Lee YW, Flora G, Pu H, Andras IE, Wylegala E, Hennig B, Nath A. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cellular and molecular neurobiology 2005, 25(1):181-199. 10.1007/s10571-004-1383-x, 15962513.
40. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berl) 1990, 80(4):393-400.
41. Flint M, Beal AEL, Ludolph AC. Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. 2005, Cambridge University Press.
42. Castelo JM, Courtney MG, Melrose RJ, Stern CE. Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise. Archives of neurology 2007, 64(9):1275-1280. 10.1001/archneur.64.9.1275, 17846265.